Connective Tissue Graft Versus Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects

July 12, 2018 updated by: Maurizio Tonetti

Connective Tissue Graft vs Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects Randomized Controlled Clinical Trial Assessing Superiority in Health Related Quality of Life and Non-Inferiority in Root Coverage

This study deals with coverage of multiple denuded roots. The current standard treatment requires surgical correction and uses soft tissue taken from the roof of the mouth to enhance results. The hypothesis of this trial is that a synthetic collagen matrix (called Mucograft) can be used to replace soft tissue taken from the subject. If the collagen matrix will prove to be equally as effective as the patient own tissue, it will be possible to avoid a more extensive surgery and decrease pain and discomfort.

Study Overview

Detailed Description

Objectives The main objective of this study is to assess if the Mucograft Collagen Matrix reduces morbidity, shortens time to recovery and improves patient based outcomes with respect to the use of autologous connective tissue graft harvested from the patient own palate when used to obtain root coverage of multiple adjacent gingival recessions.

The secondary objective is to assess the non-inferiority - in terms of complete root coverage, percentage of root coverage and professional evaluation of aesthetics - of the use of Mucograft Collagen Matrix and autologous connective tissue harvested from the patient's own palate.

Design and Outcomes This will be a parallel group, standard of care-controlled, assessor-blind, randomized, multicenter, multinational, clinical trial.

The statistical design will be a superiority trial in terms of the primary outcomes (patient based outcomes) and non-inferiority trial in terms of the professional outcomes measuring root coverage and aesthetics.

Sample size has been estimated in 140 subjects per treatment arm using a pilot case series analyzed with a multilevel statistical approach and a non inferiority margin of 0.25 mm in recession coverage.

Randomization will be performed by computer generated random codes, using random permuted blocks with a block size of 4 to avoid uneven splits and minimization for the key prognostic factor cigarette smoking. Allocation will be concealed to the surgeons until completion of preparation of the recipient bed by opaque envelopes. A central study registrar will perform patient registration.

Study locations will include academic centers and a practice-based research network in Italy, Switzerland, Germany, Belgium, France, Spain and Greece.

A single examiner, blind with respect to the treatment assignment, will perform all measurements at each center. Trained personnel not involved with the surgical intervention will: i) administer patient questionnaires, ii) provide instructions and collect patient diaries. A single calibrated investigator with specific experience in using the specific score will centrally perform assessment of esthetic scores on standardized digital images.

A biostatistician blind with respect to treatment assignment will perform the analysis.

Interventions and Duration The two intervention groups will consist of surgery with connective tissue graft (standard of care control) and surgery with the application of Mucograft Collagen Matrix (MCM, Test group). Experienced clinicians will deliver treatment consisting of root coverage surgery using coronally advanced flaps, the most utilized procedure for coverage of multiple recessions. Surgery will be standardized and the same procedures/materials will be employed to ensure consistency.

Follow-up of individual patients will be 6 months (to be extended to 3 years if funding will be available)

Study Type

Interventional

Enrollment (Actual)

187

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium
        • ICPDOI
      • Hamburg, Germany
        • Praxis Dr. Halben
      • Munich, Germany
        • Praxis Prof Huerzeler - Dr Zuhr
      • Munich, Germany
        • Praxis Prof Wachtel - Dr Bolz
      • Munster, Germany
        • Praxis Prof. Topoll
      • Athens, Greece
        • Clinic Fourmousis
      • Florence, Italy
        • University of Florence
      • Piacenza, Italy
        • Practice Prof Giulio Rasperini
      • Pisa, Italy
        • University of Pisa
      • Bilbao, Spain
        • Clinia Zabalegui
      • Malaga, Spain
        • Clinica Guerrero
      • Langenthal, Switzerland
        • Praxis Wallkamm
      • Zurich, Switzerland
        • Praxis Burkhardt

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 2-4 adjacent gingival recession (one at least 3 mm deep)

Exclusion Criteria:

  • Interdental attachment loss greater than 1 mm at recession sites

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Autologous connective tissue graft
Soft tissue harvested from patient palate
Subepithelial connective tissue graft harvested from hard palate
Other Names:
  • Subepithelial connective tissue graft
Experimental: Collagen Matrix Construct
Mucograft collagen matrix manufactured by Geistlich AG, Switzerland
Mucograft Collagen Matrix combined with rotated papilla flap
Other Names:
  • Mucograft gingival augmentation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to recovery after surgery
Time Frame: 3 months
Time to recover after surgery assessed by diary and post'op follow up professional assessment
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complete root coverage
Time Frame: 6 months
Frequency of complete root coverage
6 months
Percentage of root coverage
Time Frame: 6 months
Percentage of the exposed tooth root covered after surgical intervention
6 months
Esthetics
Time Frame: 6 months
Professional assessment by blind assessor of the esthetic result
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maurizio Tonetti, DMD PhD, The European Research Group on Periodontology (ERGOPerio)
  • Principal Investigator: Pierpaolo COrtellini, MD, The European Research Group on Periodontology (ERGOPerio)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2011

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

June 1, 2015

Study Registration Dates

First Submitted

September 22, 2011

First Submitted That Met QC Criteria

September 23, 2011

First Posted (Estimate)

September 26, 2011

Study Record Updates

Last Update Posted (Actual)

July 13, 2018

Last Update Submitted That Met QC Criteria

July 12, 2018

Last Verified

July 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gingival Recession

Clinical Trials on Autologous connective tissue graft with rotated papilla flap

3
Subscribe